BSGM - BioSig Technologies, Inc.
0.4778
-0.052 -10.925%
Share volume: 33,641
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.53
-0.05
-0.10%
Fundamental analysis
15%
Profitability
0%
Dept financing
25%
Liquidity
9%
Performance
30%
Performance
5 Days
-7.22%
1 Month
-41.01%
3 Months
-66.82%
6 Months
76.96%
1 Year
-70.51%
2 Year
-95.85%
Key data
Stock price
$0.48
DAY RANGE
$0.45 - $0.53
52 WEEK RANGE
$0.20 - $2.57
52 WEEK CHANGE
-$76.23
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
Company detail

CEO: Kenneth L. Londoner
Region: US
Website: biosig.com
Employees: 50
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: biosig.com
Employees: 50
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system. PURE EP is a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition.
Recent news
